$125 Million is the total value of Copernicus Capital Management, LLC's 20 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 116.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ISRG | Buy | INTUITIVE SURGICAL INC | $9,738,000 | +21.3% | 23,588 | +7.2% | 7.76% | +29.8% |
| CI | New | CIGNA CORPORATION | $9,226,000 | – | 55,000 | +100.0% | 7.35% | – |
| BIIB | Buy | BIOGEN INC | $9,117,000 | +56.2% | 33,296 | +81.7% | 7.26% | +67.2% |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $9,084,000 | – | 44,000 | +100.0% | 7.24% | – |
| GILD | New | GILEAD SCIENCES INC | $8,783,000 | – | 116,506 | +100.0% | 7.00% | – |
| SYK | Buy | STRYKER CORP | $8,369,000 | +35.1% | 52,009 | +30.0% | 6.67% | +44.6% |
| MOH | Buy | MOLINA HEALTHCARE INC | $7,581,000 | +110.3% | 93,382 | +98.7% | 6.04% | +125.2% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $5,573,000 | – | 50,000 | +100.0% | 4.44% | – |
| NUVA | Buy | NUVASIVE INC | $4,572,000 | +12.8% | 87,569 | +26.4% | 3.64% | +20.7% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $3,754,000 | +51.1% | 71,092 | +94.5% | 2.99% | +61.7% |
| HRTX | New | HERON THERAPEUTICS INC | $2,981,000 | – | 108,000 | +100.0% | 2.38% | – |
| CELG | New | CELGENE CORP | $2,507,000 | – | 28,100 | +100.0% | 2.00% | – |
| ARRY | New | ARRAY BIOPHARMA INC | $2,145,000 | – | 131,418 | +100.0% | 1.71% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 15 | Q2 2021 | 28.6% |
| THERMO FISHER SCIENTIFIC INC | 10 | Q3 2021 | 13.8% |
| ZOETIS INC | 10 | Q1 2020 | 13.0% |
| FATE THERAPEUTICS INC | 9 | Q3 2021 | 13.7% |
| ILLUMINA INC | 9 | Q4 2019 | 11.8% |
| BIOMARIN PHARMACEUTICAL INC | 8 | Q3 2021 | 14.7% |
| BRISTOL-MYERS SQUIBB CO | 8 | Q4 2020 | 12.2% |
| INTUITIVE SURGICAL INC | 7 | Q2 2019 | 11.8% |
| STRYKER CORP | 7 | Q2 2019 | 11.6% |
| IQVIA HLDGS INC | 7 | Q4 2020 | 8.2% |
View Copernicus Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
View Copernicus Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.